An interagency task force to fight coronavirus at the Siberian Branch of the Russian Academy of Sciences examined the first oral thrombolytic drug, Trombovazim, for use against the effects of COVID.

The State Scientific Center for Virology and Biotechnology "Vector" has begun to create biologically safe mice sensitive to the new coronavirus infection.

The Federal Medical-Biological Agency of Russia has published preliminary results of testing the anti-malaria medicine mefloquine against the coronavirus.